BONOTHYRK (peptide for parathyroid)

BONOTHYRK®  is a complex of peptide fractions received from parathyroid of young animals. The parathyroid peptides have a selective action on cells of parathyroid, they normalize metabolism and also improve their functional activity. In clinical studies was indentified the effectiveness of BONOTHYRK® for restoration of functional activity parathyroid in cases of impairment various genesis, as hyperparathyroidism, including osteoporosis, deossification, urolithiasis, muscle weakness and also hypocalcemia, numbness and muscle spasms.

Usage:

• Helps fight osteoporosis,
• During deossification and urolithiasis,
• In muscle weakness, hyperplasia parathyroid,
• At numbness and muscle spasms, caused by hypocalcemia.

Ingredients:

Content (per 1 capsule): peptide complex A-21 (parathyroids peptides), microcrystalline cellulose (E460, the flowing agent), gelatin (encapsulating agent), lactose (excipient-humectant), calcium stearate (E470, emulsifier).

Daily dose contains (2 capsules): 20 mg of peptide complex A-21.

Dosage:

Adults: 1-2 capsules 1-2 times daily before meal, for 1 month.

Repeat every 3-6 months.

Form release: 

60 capsules of 0.2 g

Guaranteed authenticity and quality:

100% Original from Peptides - Scientific and Production Center of Revitalization and Health (Russian Federation)

Development and production:

Peptides

St. Petersburg Institute of Bioregulation and Gerontology